Morgan Stanley analyst Patrick Wood maintains $Teleflex (TFX.US)$ with a buy rating, and maintains the target price at $275.
According to TipRanks data, the analyst has a success rate of 49.0% and a total average return of 7.2% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Teleflex (TFX.US)$'s main analysts recently are as follows:
Teleflex's third-quarter revenue shortfall was impacted by an unexpected OEM customer departure and weaker UroLift performance. Nonetheless, it is maintained that the core business principles of Teleflex remain solid and the company is progressing towards its margin growth objectives.
The assessment of Teleflex following its 'mixed' Q3 report suggests near-term pressures are likely to persist. Nevertheless, the prospects for the Urology segment, particularly with the momentum of Pallette, appear to be positive.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
